Gene networks modified by sulphonylureas in beta cells: A pathway-based analysis of insulin secretion and cell death

Basic and Clinical Pharmacology and Toxicology

Volumn 111, Issue 4, 2012, Pages 254-261

  Magnusson, Nils E ^a   Dyrskjøt, Lars ^b   Grimm, Daniela ^a,c   Wehland, Markus ^c   Pietsch, Jessica ^c   Rungby, Jørgen ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; HOE 33342; INSULIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL HYPOXIA; CELL SURVIVAL; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC ANALYSIS; INSULIN RELEASE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

SUS;

EID: 84866553932     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2012.00902.x     Document Type: Article

References (42)

1. Wild S, Roglic G, Green A, Sicree R, King H Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
2. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
3. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
4. Mannhold R KATP channel openers: structure-activity relationships and therapeutic potential. Med Res Rev 2004;24:213-66.
5. Gribble FM, Tucker SJ, Seino S, Ashcroft FM Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. Diabetes 1998;47:1412-8.
6. Johnsen SP, Monster TB, Olsen ML, Thisted H, McLaughlin JK, Sorensen HT et al. Risk and short-term prognosis of myocardial infarction among users of antidiabetic drugs. Am J Ther 2006; 13:134-40.
7. Ghosh S, Standen NB, Galinianes M Failure to precondition pathological human myocardium. J Am Coll Cardiol 2001;37:711-8.
8. Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, Penta de Peppo A et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 1994;90:700-5.
9. Klepzig H, Kober G, Matter C, Luus H, Schneider H, Boedeker KH et al. Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide. Eur Heart J 1999;20:439-46.
10. Lee TM, Chou TF Impairment of myocardial protection in type 2 diabetic patients. J Clin Endocrinol Metab 2003;88:531-7.
11. Cleveland JC, Jr, Meldrum DR, Cain BS, Banerjee A, Harken AH Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. two paradoxes revisited. Circulation 1997;96:29-32.
12. Maddock HL, Siedlecka SM, Yellon DM Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide. Cardiovasc Drugs Ther 2004;18:113-9.
13. Wascher TC, Boes U Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients. Clin Physiol Funct Imaging 2005;25:40-6.
14. Harrower AD Comparative tolerability of sulphonylureas in diabetes mellitus. Drug Saf 2000;22:313-20.
15. Jennings PE Vascular benefits of gliclazide beyond glycemic control. Metabolism 2000;49(10 Suppl 2):17-20.
16. O'Brien RC, Luo M, Balazs N, Mercuri J In vitro and in vivo antioxidant properties of gliclazide. J Diabetes Complications 2000;14:201-6.
17. Donath MY, Halban PA Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 2004;47:581-9.
18. Del Guerra S, Grupillo M, Masini M, Lupi R, Bugliani M, Torri S et al. Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose. Diabetes Metab Res Rev 2007;23:234-8.
19. Maedler K, Carr RD, Bosco D, Zuellig RA, Berney T, Donath MY Sulfonylurea induced beta-cell apoptosis in cultured human islets. J Clin Endocrinol Metab 2005;90:501-6.
20. Del Guerra S, Marselli L, Lupi R, Boggi U, Mosca F, Benzi L et al. Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets. J Diabetes Complications 2005;19:60-4.
21. Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 2004;145:667-78.
22. Egefjord L, Jensen JL, Bang-Berthelsen CH, Petersen AB, Smidt K, Schmitz O et al. Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis? BMC Endocr Disord 2009;9:7.
23. Ulbrich C, Pietsch J, Grosse J, Wehland M, Schulz H, Saar K et al. Differential gene regulation under altered gravity conditions in follicular thyroid cancer cells: relationship between the extracellular matrix and the cytoskeleton. Cell Physiol Biochem 2011; 28:185-98.
24. Ulbrich C, Westphal K, Baatout S, Wehland M, Bauer J, Flick B et al. Effects of basic fibroblast growth factor on endothelial cells under conditions of simulated microgravity. J Cell Biochem 2008;104:1324-41.
25. Wu Z, Irizarry RA Preprocessing of oligonucleotide array data. Nat Biotechnol 2004;22:656; author reply 658.
26. Eisen MB, Spellman PT, Brown PO, Botstein D Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-8.
27. Page RD TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996;12:357-8.
28. Magnusson NE, Cardozo AK, Kruhoffer M, Eizirik DL, Orntoft TF, Jensen JL Construction and validation of the APOCHIP, a spotted oligo-microarray for the study of beta-cell apoptosis. BMC Bioinformatics 2005;6:311.
29. Solskov L, Magnusson NE, Kristiansen SB, Jessen N, Nielsen TT, Schmitz O et al. Microarray expression analysis in delayed cardioprotection: the effect of exercise, AICAR, or metformin and the possible role of AMP-activated protein kinase (AMPK). Mol Cell Biochem 2012;360:353-62.
30. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ et al. A network-based analysis of systemic inflammation in humans. Nature 2005;437:1032-7.
31. Lang J Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem 1999;259: 3-17.
32. Gerber SH, Sudhof TC Molecular determinants of regulated exocytosis. Diabetes 2002;51(Suppl 1):S3-11.
33. Mosley AL, Ozcan S The pancreatic duodenal homeobox-1 protein (pdx-1) interacts with histone deacetylases hdac-1 and hdac-2 on low levels of glucose. J Biol Chem 2004;279:54241-7.
34. Olofsson CS, Gopel SO, Barg S, Galvanovskis J, Ma X, Salehi A et al. Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic B-cells. Pflugers Arch 2002;444:43-51.
35. Jeans AF, Oliver PL, Johnson R, Capogna M, Vikman J, Molnar Z et al. A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse. Proc Natl Acad Sci USA 2007;104:2431-6.
36. Leung YM, Kwan EP, Ng B, Kang Y, Gaisano HY SNAREing voltage-gated K+ and ATP-sensitive K+ channels: tuning beta-cell excitability with syntaxin-1A and other exocytotic proteins. Endocr Rev 2007;28:653-63.
37. Gomi H, Mizutani S, Kasai K, Itohara S, Izumi T Granuphilin molecularly docks insulin granules to the fusion machinery. J Cell Biol 2005;171:99-109.
38. Lanoix J, Ouwendijk J, Lin CC, Stark A, Love HD, Ostermann J et al. GTP hydrolysis by arf-1 mediates sorting and concentration of golgi resident enzymes into functional COP I vesicles. EMBO J 1999;18:4935-48.
39. Jewell JL, Luo W, Oh E, Wang Z, Thurmond DC Filamentous actin regulates insulin exocytosis through direct interaction with syntaxin 4. J Biol Chem 2008;283:10716-26.
40. Robertson RP, Seaquist ER, Walseth TF G proteins and modulation of insulin secretion. Diabetes 1991;40:1-6.
41. Hardie DG, Sakamoto K AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda) 2006;21:48-60.
42. Towler MC, Hardie DG AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007;100:328-41.